CHRC Stock Overview
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Chr. Hansen Holding A/S Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr.554.20 |
| 52 Week High | kr.559.10 |
| 52 Week Low | kr.470.65 |
| Beta | 0.33 |
| 1 Month Change | 1.50% |
| 3 Month Change | n/a |
| 1 Year Change | 8.16% |
| 3 Year Change | -1.96% |
| 5 Year Change | -13.30% |
| Change since IPO | 251.65% |
Recent News & Updates
Recent updates
Shareholder Returns
| CHRC | GB Chemicals | GB Market | |
|---|---|---|---|
| 7D | 0.1% | -0.2% | 0.4% |
| 1Y | 8.2% | -30.1% | 6.2% |
Return vs Industry: CHRC exceeded the UK Chemicals industry which returned -44% over the past year.
Return vs Market: CHRC exceeded the UK Market which returned -5.1% over the past year.
Price Volatility
| CHRC volatility | |
|---|---|
| CHRC Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 6.9% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in GB Market | 11.1% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: CHRC has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CHRC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1843 | 3,834 | Mauricio Graber | www.chr-hansen.com |
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments. The Food Cultures & Enzymes segment produces and sells various cultures, enzymes, and probiotic products that determine the taste, flavor, texture, shelf life, nutritional value, and health benefits of various consumer products in the food industry, primarily in the dairy industry.
Chr. Hansen Holding A/S Fundamentals Summary
| CHRC fundamental statistics | |
|---|---|
| Market cap | kr.72.33b |
| Earnings (TTM) | kr.1.69b |
| Revenue (TTM) | kr.9.94b |
42.8x
P/E Ratio7.3x
P/S RatioIs CHRC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CHRC income statement (TTM) | |
|---|---|
| Revenue | €1.33b |
| Cost of Revenue | €611.10m |
| Gross Profit | €723.30m |
| Other Expenses | €496.30m |
| Earnings | €227.00m |
Last Reported Earnings
Aug 31, 2023
Next Earnings Date
Apr 04, 2024
| Earnings per share (EPS) | 1.72 |
| Gross Margin | 54.20% |
| Net Profit Margin | 17.01% |
| Debt/Equity Ratio | 52.0% |
How did CHRC perform over the long term?
See historical performance and comparison